phenothiazine derivatives (especially promethazine hydrochloride and chlorpromazine) and tetrachlorosalicylanide (a soap germicide) have become prominent in this regard (Wilkinson 1961 a,b) .
A discussion on contact dermatitis from drugs raises many problems of the biological behaviour of the skin, cutaneous absorption, genetics, immunology, chemistry, and legislation. Bruno Bloch, and later Rostenberg (1957) , have tried to express in a formula' the factors determining why an individual becomes sensitized to a contactant. One of the few measurable factors is the concentration of the drug; sensitizing power is directly proportional to it. The best way to reduce the incidence of reactions is to use the minimal concentration necessary for the minimal period of time. The strength of drugs in eardrops is often unnecessarily high. Apart from the concentration of the substance and the manner of its percutaneous absorption, trauma to the skin surface, seasonal and climatic changes, and previous environmental exposure to the allergen are all relevant. Some disruption of the integrity of the barrier layer of the stratum corneum is necessary to initiate sensitization with the majority of drugs in common use, and presumably the eczema process facilitates reactions to medicaments by this mechanism as well as making absorption easier. Most physicians agree that reactions to drugs are commoner on eczematous skin; since drugs are used so little on normal skin, this is difficult to prove. Examples of crosssensitivity steadily multiply. Some chemical configurations are notoriously potent sensitizers, such as para-amino,and thiol groups, hydrazines and halogenated nitrobenzenes. Although these substances may not be used themselves, derivatives are sometimes mistakenly regarded as safe. Furthermore, because of the different immunological mechanism involved, drugs which rarely cause reactions when administered systemically may be potent contact sensitizers. Examples are hydrallazine, isoniazid and dimercaprol. Legislation is not the most desirable means of drug control, and experience has shown that the Food, 1 Gf x Aq ;>-K =S where G ==the genetic make-up of the host A=the intrinsic allergenicity of the compound f=adventitious factors which may influence the sensitizability of the host at that time q =quantitative factors K=some theoretical level which the product of Gf x Aq must reach in order for a sensitization to be detectable clinically S=detectable sensitivity (Rostenberg 1957) Drug and Cosmetics Act of the United States does not prevent sensitizing compounds from reaching the market. This is partly because efficient means to identify such compounds have not yet been devised. However, two experiences of prophylactic legislation are of some interest. Paraphenylenediamine is not permitted to be used in Denmark, and cases of sensitivity to this compound are extremely rare, in contrast to their frequency in other countries (Hjorth 1960, personal communication) . In 1958 the use of ammonium persulphate in bread was forbidden in Western Germany. Since that time bakers' dermatitis has virtually disappeared (Preyss 1960 My approach to this somewhat overwhelming subject can only be clinical; I have nothing new to describe and shall confine myself to the problems as they present in the wards and clinics. Skin eruptions provoked by drug ingestion have been long recognized and while it is probably true to say that no drug exists which at some time or another may not provoke a skin reaction in a susceptible person, there are certainly many drugs which are peculiarly liable to do so. When one considers the increasing number of chemicals flowing on to the market to become available for medical use it is obviously trite to say that one must ever be alert for new and unsuspected drug reactions. A current list of those commonly causing trouble in 1961 would surely be headed by penicillin and followed by the sulphonamides, barbiturates, other antibiotics, antituberculous drugs, carbromal and phenolphthalein. A list made, for instance, in 1931 would have included gold, arsenic, mercury, phenazone, bromides and iodides. Presumably, thirty years hence the troublemakers will again be different.
The skin as the target for such inflammatory behaviour has a limited repertoire of reactions with which to show its displeasure; the urticarial and the eczematous, the vascular and the erythematous being common examples; though all of these may develop in response to drugs, they are frequently induced by other means. There are a few patterns such as the fixed eruption especially to be suspect as drug induced and it is fair to say that in the role of the great imitator so far as rashes are concerned, modern drugs have now replaced syphilis. A list of some of the possible reactions that may result will include: acneiform, generalized erythema, erythemato-vesicular, exfoliative dermatitis, lichenoid, vesiculo-bullous, purpuric, necrotizing vasculitis, erythema nodosum, Arthus phenomenon, urticaria.
It is a mistake, however, to think that the skin is the only organ involved, for there is frequently a widespread disturbance in which the liver, reticulo-endothelial and hemopoietic systems, lungs and kidneys may participate. The fact that the rash is so readily apparent should not blind us to these other features.
Though we are ignorant about the mechanisms concerned in an individual reaction it is obviously wrong to attribute all drug reactions to allergy. As yet there is no satisfactory means for substantiating an allergic basis and until one is available it must generally be assumed by implication.
A common, though flattering, misconception is that a dermatologist by glancing at a rash can immediately denounce the offending drug with accuracy. But, alas, with few exceptions, this is rarely possible. The fixed eruption is not provoked in the absence of a drug; the acneiform and the pseudo-epitheliomas induced by halogens are virtually specific; the pigmentary changes produced by the heavy metals and the keratoses and neoplastic effects of arsenic are also fairly typical, but we probably gain the greatest kudos by recognizing the very special appearance of the carbromal eruption. Apart from these one has to accept the fact that many different drugs can produce the same clinical picture and that the same drug may produce different patterns in different persons; and finally the same drug may in the same person produce different patterns in succeeding episodes.
Among the out-patients attending St John's Hospital for Diseases of the Skin, London, it is carbromal which still heads the list for this group. This gentle hypnotic is found in a large number of proprietary tablets. The characteristic eruption consists of punctate hemorrhages, rusty staining suggesting cayenne pepper, associated with superficial scaly eczematous patches. It first appears around the ankles and feet spreading gradually up the legs to the thighs and buttocks; the rash is irritable and takes a long time to fade once the drug is stopped. Capillary fragility is increased but thrombocytopenia is not the rule. Once the eruption has subsided a small test dose by mouth will generally provoke a violent exacerbation of symptoms. Meprobamate is said to produce a similar eruption and cross-sensitivity between these two drugs has been recorded.
The fixed eruption has a striking clinical picture consisting of well-defined circular or oval erythematous patches; they are dusky in colour and leave pigmentation behind when they subside. The surface may be dry, scaly, exudative or bullous and symptoms of burning or itching are usual. Fixed eruptions may occur anywhere on the body surface even on a mucous membrane and they are peculiarly liable to affect the male genitalia. Their most characteristic feature is that the same skin sites are involved in each attack. It is the phenolphthalein used in so many proprietary purgatives which causes most of the fixed eruptions but other drugs such as phenazone, barbiturates, sulphonamides and even tetracyclines may account for them from time to time. The term 'fixed' is used because the reactions occur in the same fixed area suggesting that antibody is in some way attached to cells at these particular sites. Neither patch or scratch tests of affected or unaffected areas yield uniform results while auto-transplants of skin interchanging unaffected and affected and vice versa do not provide conclusive evidence that antibody is in fact fixed in these areas.
Of the generalized reactions, urticaria and the angio-cedema group are most commonly attributable to the antibiotics especially penicillin. Passive transfer has been reported and the group stands up well to stringent criticism of its allergic basis. A notable feature with penicillin urticaria is the length of time the symptoms may persist; I have seen it continue for a year.
The occasional person who reacts with asthma or an acute eruption, generally urticarial, as a manifestation of aspirin sensitivity, is familiar. The role of aspirin in aggravating symptoms in patients plagued by chronic urticaria may not be so well known. Warin (1960) reported 70 patients who were subject to chronic whealing and itching and in 22 exacerbations of the urticaria invariably followed ingestion of aspirin or salicylates in various forms.
The Erythemas
The scarlet-fever-and measles-like eruptions, the maculopapular and the blotchy, in my experience provide the greatest diagnostic difficulty. Fre-quently such eruptions occur in patients already in hospital and more often than not they are taking a variety of drugs all of which could possibly provoke the rash. Itching, fever and lymphadenopathy are variable features. For instance, one may commonly see a patient with such an eruption and find that he is taking salicylates, barbiturates, sulphonamides and an antibiotic.
A frequent clinical story is that one is called to see a patient with such a diagnosis in mind only to discover that all the drugs have already been stopped, the rash is beginning to fade and the patient's discomfort is lessening. The house physician has prescribed antihistamines by mouth and some soothing application for the skin. It is often impossible to be sure which drug is to blame and the best we can do is to suggest the culprits in order of likelihood. It is disappointing that often we have not the time or opportunity to prove the guilt and in fact occasionally when we do have this chance it is humiliating to find that administration of the drugs singly does not result in a further eruption.
Erythema multiforme and the so-called Stevens-Johnson syndrome in which the inflammatory changes are most marked at the mucocutaneous junctions, the mouth, the vulva and the eyes, may be provoked by a multitude of various factors. Just as we accept that erythema nodosum may be an expression of bacterial sensitivity, of sarcoidosis, or of sulphathiazole sensitivity, we appreciate that erythema multiforme is but a comparable process resulting from a more superficial inflammatory reaction. Erythema multiforme is often triggered off by bacterial and viral infections, but is also provoked by sulphonamides, barbiturates and many other drugs.
Exfoliative dermatitis may occasionally result from a drug reaction, in which case the heavy metals such as gold and mercury, or the antimalarial drug mepacrine, are most likely to be responsible. It is comparable to naturally occurring erythrodermia which may stem from chronic eczema, psoriasis or some relatively banal condition in that, once established, it seems that generalized exfoliation becomes an ingrained habit of the skin's behaviour, a sort of perpetual motion continuing without further stimulus. Most of the druginduced erythrodermias must surely be toxic in their origin, though possibly a few follow a hypersensitivity reaction. Chloroquine, when given to patients with psoriasis, frequently induces complete exfoliation after some three weeks of treatment, whereas arsenic and mercury, themselves capable of inducing erythrodermia, have both been used with great success in the treatment of psoriasis. If the heavy metals interfere with a chemical or enzyme process important in the psoriatic reaction, it may be that chloroquine influences or even enhances this fault.
It is this group of erythemas, erythema multiforme and erythrodermias which clinicians find so baffling in that sometimes a hypersensitivity mechanism seems most likely while in others a toxic basis must be assumed. It is here particularly that help is needed not only from allergists and immunologists, but also from the microchemist working at cellular levelhe will soon surely be able to reveal evidence of toxic interference with natural chemical processes and then this group should be better understood.
Lichenoid eruptions too, like the pigmentary disturbances, are surely toxic in origin; they follow the same group, that is the heavy metals and the antimalarials. It seems that the skin can produce a lichenoid reaction while already involved in some other type of inflammatory process; for instance, a patient with pemphigus treated by systemic steroids produced a widespread lichenoid reactionwhile on a mercurial diuretic, and this while he was receiving huge doses of cortisone. Similarly, a patient with lichen planus being treated by steroids produced an erythema-multiforme-likedrugreaction fromdichloral phenazone, and this again did not settle until the causal drug was replaced by a barbiturate.
Photosensitivity
Skin reactions resulting from enhanced sensitivity to sunlight can be produced by drugs and it has been suggested that two mechanisms may be involved, the phototoxic in which an exaggerated sunburn reaction occurs, or photo-allergy in which sensitivity is somehow induced so that the skin once exposed to sunlight reacts in an eczematous manner. Erythema of the exposed parts following oral sulphonamides was reported by Grant Peterkin (1945) from North Africa during the last war. Morerecent drugs with similar propensities are the antihistamine, promethazine, and chlorpromazine, which is closely related to promethazine. There may be a cross-sensitivity in such patients. The wave-band responsible for photosensitivity is precisely definedaround 3,000 A; only summer sunlight therefore need be considered. Other drugs which may occasionally produce photosensitivity are the newer sulphonamides, as well as the diuretic and the antidiabetic modifications. A new antibiotic, dimethylchlortetracycline, seems to be a potent photosensitizer; the eruption resulting may be eczematous or an enhanced sunburn reaction, a striking feature being the frequency with which shedding of the distal part of the nails has been reported.
Toxic epidermal necrolysis is a rare condition characterized by extensive areas of the skin becoming erythematous to be followed by shedding of sheets of epithelium leading to extensive denuded raw areas. Sometimes flaccid blisters have been seen, so Lyell (1956) who first described the condition in this country likened the appearance to scalding of the skin. His suggestion was that this was yet another manifestation of drug sensitivity since when phenolphthalein, sulphonamides and dapsone have been incriminated.
The fact that there is no simple skin or laboratory test to confirm an allergic hypersensitivity means one has to resort to the administration of a challenging dose using a small amount of the suspected drug. There is some danger in this procedure, which must be carried out with skill; for instance, an iodine-sensitive patient could conceivably be induced to develop a widespread vasculitis and an urticarial patient might well develop severe angio-aedema or an alarming anaphylactic reaction. However, for the erythemas, erythema multiforme and the fixed eruptions there is no great danger if the test dose is extremely small, the patient is under constant observation and some time has elapsed since complete recovery from the previous inflammatory episode. A positive result will be revealed by a recurrence of an erythema and itching, possibly with a slight rise in temperature. Increase in circulating eosinqphils or an immediate drop in platelets has been frequently reported but reliance should not be placed on these observations.
It is the slight danger, the time factor and the ready availability of alternative drugs which makes physicians somewhat chary of undertaking this type of test. Furthermore, patients are often reluctant to undergo it and I believe that they should always be consulted. There are, however, conditions when precise incrimination is important, notably in tuberculous patients sensitive to PAS or lepers sensitive to sulphones when suitable alternatives are not readily available.
When a challenging dose is prescribed and no reaction develops, the explanation may be:
(1) The drug itself is not the cause ofthe condition.
(2) The patient is in a phase of non-reactivity.
(3) The reaction was not an allergic but a toxic one. (4) A combination of drugs is required to produce the effect.
This combined effect may occur with antituberculous drugs. Streptomycin frequently pro-vokes reactions of the hypersensitivity pattern, and Keefer & Hewitt(1948) report 11 % of patients producing some reaction though, unlikepenicillin, succeeding courses of treatment produced less and less reaction. Streptomycin may induce fever and erythema early on, and yet may be tolerated if a course of treatment is pursued. The common picture of erythema or urticaria and even occasionally generalized exfoliation may occur between the 4th and 14th day, but according to Bunn & Westlake (1949) some three-quarters of these patients will later be able to continue with the antibiotic suggesting that desensitization has occurred.
Surprisingly little trouble was produced by PAS in the early days (in only 2% of patients) though more recent reports suggest that reactions now occur more frequently. The skin reactions are of the various erythematous types with fever, lymphadenopathy and liver damage, though the latter is infrequently seen with streptomycin. A helpful differential point is that fever starts later with PAS than with streptomycinaround the tenth to the twenty-fifth dayand it seems to be progressive. Isoniazid virtually never causes skin reactions.
That double or even multiple sensitivities may develop simultaneously was illustrated by a patient described by Jeffery et al. (1952) . A violent cutaneous and systemic reaction was provoked in a young woman after three weeks' administration of streptomycin and PAS. Subsequent testing revealed that she was indeed sensitive to both drugs; furthermore she later developed sensitivity to penicillin. I have seen a patient with renal tuberculosis who developed a severe exfoliative reaction with fever and lymphadenopathy. Stopping all drugs allowed the patient gradually to recover and later he received a challenging dose first of isoniazid, then with streptomycin and finally with PAS. Each drug in turn was followed by a recurrence of fever with a new attack of erythema. Luckily for this patient his general progress was such that further chemotherapy at this time was not needed. Two years later, however, there was some progression of his disease and further treatment had to be contemplated; the three drugs once again were given separately and again they all provoked febrile erythematous reactions in turn. This is a good demonstration of the long-lasting state of hypersensitivity and also that the apparently innocuous drug isoniazid may occasionally be induced to exert an antigenic role.
It is not for me to discuss skin testing in these conditions, but wemaynote thatin these drugreactions the chemical itself has to become linked to a protein such as albumin before it can assume an antigenic role, thus the common sensitizers like penicillin are the ready protein linkers. This fact must partly explain the fallibility of both patch and scratch testing; positive results may develop but the results are so equivocal that reliance should not be placed on them. What we need is the means to separate the allergic from the toxic reaction with assurance, and until this becomes available we must guess, albeit with inspiration.
Skin Testing and Desensitization to Drugs by A W Frankland MA DM (London)
Before considering whether information can be obtained of drug sensitivity in a patient by means of skin testing, brief mention must be made of some of the basic immunological problems involved when a patient reacts in some untoward way to a drug. We have always to think in general terms in any allergic reaction whether it is of the 'immediate' or the 'delayed' type. The problem is a complex one because we often do not know the actual 'antigen' that causes the reaction. Even if a low molecular drug has to combine with serum protein to become a hapten, there may have to be many hapten molecules attached to a protein molecule before the molecule develops specific immunological properties. In some cases drugs only sensitize when they are subject to oxidation. Phenothiazine normally causes no trouble, but if allowed to stand and change colour, anyone who touches it develops a dermatitis (Williams 1958) . While there are many difficulties in knowing what antigen causes a reaction, antibodies are particularly difficult to characterize. The immunologists now have many very sensitive techniques to study antibody formation, but unfortunately the antibodies that may occur with a drug reaction are not necessarily directly related to the reaction. Failure to demonstrate antibodies may not mean that they are not there. It has been found that the presence of a tuberculin antibody in the x globulins, can be masked by the y globulins of whole serum.
It seems certain that many cutaneous drug eruptions have no immunological basis but are determined by enzyme interference such as the pellagra dermatitis due to isoniazid (Harrison & Feiwel 1956) or to a genetically determined deficiency such as occurs in favism and primaquine sensitivity.
Patch Testing and Drug Sensitivity Patch testing with offending allergens to prove a specific sensitivity has been in use in England since 1645 (Macalpine & Hunter 1956 . It is often no easy matter to decide whether a positive patch test is a specific allergic response or whether it is quite non-specific, or whether the clinical reaction is truly allergic or not. The patch test aims to be a specific procedure which will reproduce the skin lesion on an uninvolved area of skin. Various textbooks on dermatology will give both the diluting material and the strength of the testing preparation (Schwartz et al. 1957) . There is only general agreement as to the strength of testing material that should be used and often widely different strengths are advised by different authors and there is no agreed standard patch test procedure.
False positive responses are not uncommonly seen in eczematous patients particularly in patients who have an epidermal sensitivity. The threshold of reactivity is particularly inconstant as it is lower in the eczematous patient than the normal and varies according to the phase of the eczema (Wilson 1955) . A nonspecific state of increased sensitivity rather than a true epidermal allergy seems particularly liable to occur during an acute phase of a contact sensitivity. It may be possible to distinguish between a primary irritant and an allergic reaction by retesting after several weeks using dilutions of the test substance. One of the three following patterns may be seen:
(1) The true allergic reactionerythema, cedema and vesicles, the reaction diminishing very gradually as the test substance is diluted. (2) The irritant reactioncausing erythema, oedema and follicular papulesmay become necrotic but fades quickly as the test substance is diluted.
(3) A nonspecific false positiveerythema and cedema appearing with some dilutions and not others.
It may be sometimes very difficult to decide whether a response is a true allergic reaction or an irritant reaction as, in a reactive skin, low concentrations may give a typical positive response. On retest in a few months this may have become negative. The problem of photosensitization by drugs illustrates some of our difficulties in interpretation of patch testing. Photosensitization is no new problem but the widespread use of chlorproma-
